TransMedics

TransMedics is a medical device company founded in 1998 that specializes in portable warm blood perfusion systems for organ transplantation. The company’s core technology, the Organ Care System (OCS), maintains organs in a near-physiologic state outside the human body. Key product offerings include the OCS Heart, OCS LUNG, and OCS Liver systems, which enable surgeons to perfuse and ventilate organs between donor and recipient sites. These systems represent a significant advancement in transplant technology, moving beyond traditional cold storage methods to improve organ viability and clinical outcomes.

Operating with 500-1,000 employees, TransMedics maintains a focused operational footprint. Learn about TransMedics's global headquarters for geographic details regarding their facility in Andover, Massachusetts. The company’s infrastructure supports the manufacturing and distribution of its proprietary perfusion consoles and disposable components, ensuring high-volume clinical adoption across international markets, including Europe and Australia. By integrating advanced monitoring and ventilation capabilities, the firm addresses critical challenges in the organ transplant supply chain.

TransMedics, trading under the ticker NASDAQ: TMDX, has demonstrated robust growth in the medical technology sector. The company reported annual revenue of $635.9M, reflecting its strong market position and the increasing clinical adoption of its ex-vivo perfusion solutions. Meet TransMedics's team to learn about their leadership and organizational structure, or Explore financial highlights for detailed metrics on their funding history and fiscal performance. The company continues to compete with firms like Inari Medical and CareDx, leveraging its specialized technology to drive innovation in the transplant field.